Circulating proteins as lung cancer biomarkers, including carcinoembryonic antigen [9], Cyfra21-1 [10], CA199 [11], and CA125 [12], have been widely used in lung cancer diagnosis. This evidence concerns the gene CEACAM5 and lung cancer.